Kevin J. Appelbaum - 20 Dec 2021 Form 4 Insider Report for Better Therapeutics, Inc.

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Mark Heinen, Attorney-in-Fact for Kevin J. Appelbaum
Issuer symbol
BTTX on OTC
Transactions as of
20 Dec 2021
Net transactions value
+$4,600
Form type
4
Filing time
22 Dec 2021, 17:03:31 UTC
Previous filing
17 Dec 2021
Next filing
04 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BTTX Common Stock Purchase $4,600 +1,000 +36% $4.60* 3,750 20 Dec 2021 Direct
holding BTTX Common Stock 2,406,719 20 Dec 2021 By Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are owned directly by Kevin Appelbaum, or his successor(s), as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated May 16, 2020, as amended (the "Trust"), and indirectly by Mr. Appelbaum as trustee of the Trust. Mr. Appelbaum is an officer, director and ten percent owner of the Issuer.